November 24, 2008 – Earlier this year, the FDA issued a warning to companies selling a drug called colchicine in injectsble form. Colchicine is an anti-inflammatory commonly used to treat gout and prevent gout attacks. It is approved by the FDA in its oral tablet form. However, some manufacturers have created an injectable version for the treatment of acute cases of gout. Injectable, intravenous colchicine is highly toxic and there is a very narrow margin between a safe and an unsafe dose. Intravenous colchicine can be fatal. As of 2007, more than 23 deaths were reported as a result of the drug. Other side effects include abdominal pain, vomiting, seizures, diminished platelet and blood cell production, and organ failure. The FDA Advisory can be found here.
Product News and Recalls
Attorney advertising. Attorneys at Lopez McHugh LLP are licensed in Pennsylvania, California, New Jersey, New York, Iowa, and Washington, D.C. We may associate with attorneys from other states. No representation is made that the quality of the legal services to be performed is greater than the quality of legal services performed by other lawyers. Past results are not a guarantee of future performance. Further, attorneys at Lopez McHugh LLP are not certified as specialists in any field. The hiring of a lawyer is an important decision that should not be based solely upon advertisements. The information on this page is provided for informational purposes only and is not intended to express or constitute legal or medical advice to any reader, may not apply to your specific factual or legal circumstances and may not be complete or up-to-date, nor does it create an attorney-client relationship. You should always consult directly with a qualified attorney for legal advice. Free consultation: In most cases, we represent clients on a contingency fee basis. This means that there is no up-front cost, but we will be reimbursed for expenses and charge a fee in the event that we receive a recovery on your behalf. If you agree in writing to hire us, we will make reasonable efforts to contact you when necessary. You, however, have an obligation to provide current contact information and to communicate with us so that we can properly investigate and, where appropriate, pursue your claim.